Iran J Pharm Res. 2013;12(2):367-79.

Effect of Laurus nobilis L. Essential Oil and its Main Components on α-glucosidase and Reactive Oxygen Species Scavenging Activity.

Iranian journal of pharmaceutical research : IJPR

Serap Sahin Basak, Ferda Candan

PMID: 24250611 PMCID: PMC3813252

Abstract

The present study was designed to determine the effects of the essential oil of Laurus nobilis L. (Lauraceae) and its three main components on α-glucosidase and reactive oxygen species scavenging activity. The chemical composition of the essential oil from Laurus nobilis L. leaves was analyzed by GC/GC-MS and resulted in the identification of 29 compounds, representing 99.18% of the total oil. 1,8-cineole (68.82%), 1-(S)-α-pinene (6.94%), and R-(+)- limonene (3.04%) were determined to be the main components. The antioxidant features of the essential oil and its three main components were evaluated using inhibition of 2,2-diphenyl-1- picrylhydrazyl, hydroxyl, and superoxide radicals, inhibition of hydrogen peroxide and lipid peroxidation assays. The results show that the DPPH, hydroxyl, and superoxide radical as well as hydrogen peroxide scavenging activities of the essential oil are greater than the positive controls and the three main components of the oil when tested independently. The inhibition of lipid peroxidation by the oil occurred less frequently than with 1,8-cineole and R-(+)- limonene alone, but the effects were more pronounced than those seen with 1-(S)-α-pinene and the positive controls. An α-glucosidase inhibition assay was applied to evaluate the in-vitro antidiabetic activity of the essential oil. IC50-values were obtained for laurel essential oil, 1, 8-cineole, 1-(S)-α-pinene, and R-(+)-limonene: 1.748 μL/mL, 1.118 μL/mL, 1.420 μL/mL and 1.300 μL/mL, respectively. We also found that laurel essential oil and 1, 8-cineole inhibited the α-glucosidase competitively while 1-(S)-α-pinene and R-(+)-limonene were uncompetitive inhibitors.

Keywords: 1; 1-(S)-α-pinene; Essential oil; 8-cineole; Laurus nobilis L.; R-(+)-limonene; α-glucosidase

References

1. Biol Pharm Bull. 2007 Jul;30(7):1217-20 - PubMed
2. Phytother Res. 2003 Apr;17(4):376-9 - PubMed
3. J Agric Food Chem. 2004 Dec 29;52(26):8255-60 - PubMed
4. Biol Pharm Bull. 2006 Oct;29(10):2056-64 - PubMed
5. Anal Biochem. 1979 Jun;95(2):351-8 - PubMed
6. J Food Prot. 2007 Jul;70(7):1704-9 - PubMed
7. Phytother Res. 2003 Aug;17(7):733-6 - PubMed
8. Am J Med. 1991 Sep 30;91(3C):14S-22S - PubMed
9. Oncol Rep. 2002 Jul-Aug;9(4):757-60 - PubMed
10. Asia Pac J Clin Nutr. 2004;13(4):401-8 - PubMed
11. Phytother Res. 2004 Sep;18(9):713-7 - PubMed
12. Food Chem Toxicol. 2004 Apr;42(4):579-84 - PubMed
13. Food Chem Toxicol. 2008 Feb;46(2):446-75 - PubMed
14. J Ethnopharmacol. 2006 Nov 3;108(1):31-7 - PubMed
15. Mycopathologia. 2006 Feb;161(2):119-28 - PubMed
16. Biosci Biotechnol Biochem. 1993 Jan;57(1):123-4 - PubMed
17. J Ethnopharmacol. 2003 Apr;85(2-3):283-7 - PubMed
18. Carcinogenesis. 1989 Jun;10(6):1003-8 - PubMed
19. J Biochem Mol Toxicol. 2003;17(1):24-38 - PubMed
20. Biochem Pharmacol. 1988 Mar 1;37(5):837-41 - PubMed
21. J Agric Food Chem. 2002 Mar 13;50(6):1492-6 - PubMed
22. J Ethnopharmacol. 2004 Jul;93(1):117-21 - PubMed
23. Anticancer Res. 2007 Sep-Oct;27(5A):3293-9 - PubMed
24. Phytother Res. 2000 Jun;14(4):240-4 - PubMed
25. Arch Iran Med. 2009 Mar;12(2):121-7 - PubMed
26. Singapore Med J. 2005 Jul;46(7):322-4 - PubMed
27. Planta Med. 1995 Feb;61(1):33-6 - PubMed
28. Curr Diabetes Rev. 2008 Feb;4(1):46-54 - PubMed
29. Clin Chim Acta. 2004 Aug 16;346(2):161-70 - PubMed
30. J Ethnopharmacol. 2006 Jan 3;103(1):85-9 - PubMed
31. J Med Food. 2005 Fall;8(3):408-11 - PubMed
32. Chem Senses. 2001 Mar;26(3):281-92 - PubMed
33. Adv Exp Med Biol. 1996;401:131-6 - PubMed

Publication Types

• Journal Article